Discover all you need to know about stealth mode biotech startups, including what stealth mode is and its advantages and ...

Reuters.com is your online source for the latest news stories and current events, ensuring our readers up to date with any ...

Pfizer and Moderna are set to begin shipping millions ... immunocompromised can also get a medicine called pemivibart, whose brand name is Pemgarda. Given intravenously in a medical facility ...

Her name is inspired by Duchamp’s iconic ready-made, the urinal entitled Fontaine, and a famous brand of French notebooks (Clairefontaine ... Galerias Municipais, Lisbona, 2019; La Borsa e la vita, ...

A roundup of the newest places to go and exhibitions to visit during the upcoming fashion week, running from Tuesday to ...

Shares of Moderna Inc. MRNA slipped 3.43% to $65.69 Friday, on what proved to be an all-around mixed trading session for the ...

Moderna said that the Canadian government has approved its updated Covid-19 Spikevax for individuals aged six months and older. The biotechnology company on Tuesday said that Health Canada authorized ...

UCG / Contributor / Getty Images Moderna shares surged Tuesday after Canadian regulators approved the biotech firm’s updated COVID-19 vaccine. Moderna's Spikevax KP.2 targets the KP.2 variant of ...

Expanding its portfolio into oncology and rare diseases, positions Moderna to deliver ten product approvals within the next three years. The analyst notes the COVID-19 vaccine maker pushed its ...

Moderna’s mRNA cancer vaccine for solid tumours shows early signs of promise in interim data from a Phase I study. The messenger ribonucleic acid (mRNA) specialist announced the vaccine has ...

chief brand officer at Moderna. “This campaign is centered on how many people truly depend on us to be reliable and present, whether for day-to-day needs or something more meaningful like having ...

Moderna said Thursday it would cut its annual spending on research and development by 23%, or $1.1 billion, between 2024 and 2027 in a concession to investors who have viewed the company’s ...